AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Check-Cap CHEK shares increased by 111.7% to $1.57, while bioAffinity Technologies BIAF stock rose by 23.79% to $0.34. Adaptimmune Therapeutics ADAP shares increased by 9.82% to $0.06 and GlucoTrack GCTK stock moved upwards by 9.51% to $11.51. Losers included Kalaris Therapeutics KLRS stock, which fell 7.0% to $3.62, and China SXT Pharmaceuticals SXTC shares, which declined by 5.53% to $1.88.
In the healthcare sector, several stocks experienced significant movements during Friday's after-market session. Check-Cap (CHEK) shares surged by an impressive 111.7%, reaching $1.57, while bioAffinity Technologies (BIAF) stock rose by 23.79% to $0.34. Adaptimmune Therapeutics (ADAP) shares increased by 9.82% to $0.06, and GlucoTrack (GCTK) stock moved upwards by 9.51% to $11.51. Meanwhile, Kalaris Therapeutics (KLRS) stock fell by 7.0% to $3.62, and China SXT Pharmaceuticals (SXTC) shares declined by 5.53% to $1.88 [2].Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet